On August 4, Procter & Gamble agreed to buy Thorne for $3.8bn. Thorne spent four decades building credibility with practitioners, athletes and consumers who read certificates of analysis before buying, so the reaction was predictable: what happens to quality when a trusted independent supplement company becomes a line item inside a global corporation?